Hyundai Pharm (004310) — Free Cash Flow Generation Index

Latest as of May 2026: 0.54x

Hyundai Pharm (004310) has a Free Cash Flow Generation Index of 0.54x as of May 2026. Free cash flow of ₩1.30 Billion represents 1% of operating cash flow (₩2.39 Billion). Explore Hyundai Pharm capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.54x
Free Cash Flow / Operating CF

Free Cash Flow

₩1.30 Billion
KRW

Operating Cash Flow

₩2.39 Billion
KRW

Capital Expenditures

₩1.09 Billion
KRW

Hyundai Pharm Free Cash Flow Generation Index (2010–2022)

Historical FCF Generation Index trend for Hyundai Pharm across 8 annual periods. For the full cash flow conversion analysis, see Hyundai Pharm operating cash flow efficiency.

Annual Free Cash Flow Generation for Hyundai Pharm (2010–2022)

Year-by-year Free Cash Flow Generation Index for Hyundai Pharm. Check 004310 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2022 0.43x ₩5.04 Billion ₩11.62 Billion ₩6.58 Billion ▲ +232.7%
2021 -0.33x ₩-1.68 Billion ₩5.13 Billion ₩6.81 Billion ▼ -180.2%
2020 0.41x ₩4.40 Billion ₩10.80 Billion ₩6.40 Billion ▼ -15.4%
2019 0.48x ₩3.35 Billion ₩6.96 Billion ₩2.36 Billion ▲ +712.5%
2018 0.06x ₩168.09 Million ₩2.83 Billion ₩2.67 Billion ▼ -95.4%
2013 1.28x ₩10.19 Billion ₩7.95 Billion ₩2.24 Billion ▼ -19.3%
2011 1.59x ₩9.95 Billion ₩6.27 Billion ₩3.68 Billion ▼ -35.8%
2010 2.47x ₩6.62 Billion ₩2.68 Billion ₩3.95 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).